[Translation] A randomized, double-blind, placebo-controlled, multi-center bridging clinical study of TY1801J in the treatment of mild to moderate toenail mycosis
主要目的:
1. 评价TY1801J治疗轻中度趾甲真菌病受试者的有效性,与境外临床试验的有效性数据进行桥接。
次要目的:
1. 进一步评价TY1801J治疗轻中度趾甲真菌病受试者的安全性。
2. 进一步评价TY1801J治疗轻中度趾甲真菌病受试者的有效性。
3. 评价导致趾甲真菌病的皮肤癣菌对TY1801J的药物敏感性。
[Translation] main purpose:
1. Evaluate the effectiveness of TY1801J in treating subjects with mild to moderate toenail mycosis, and bridge it with the effectiveness data of overseas clinical trials.
Secondary purpose:
1. Further evaluate the safety of TY1801J in the treatment of subjects with mild to moderate toenail mycosis.
2. Further evaluate the effectiveness of TY1801J in treating subjects with mild to moderate toenail mycosis.
3. To evaluate the drug susceptibility of dermatophytes that cause toenail mycosis to TY1801J.